Clinical Trials Sponsored by Yunnan PanLongYunHai Pharmaceuticals, Ltd.

Total 21 results

LongStar HealthPro, Inc. DBA Farlong Pharmaceutical
KGK Science Inc.; Yunnan PanLongYunHai Pharmaceuticals, Ltd.

Completed

The Effect of Farlong® NotoGinseng™ (Ginseng Plus®) on Cholesterol and Blood Pressure

Hypertension | Hyperlipidemias
Hunan Kelun Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Gefitinib Tablets Under Fed Conditions

Healthy
Hunan Kelun Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions

Bioequivalence Study
Hunan Cancer Hospital
Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Recruiting

A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Hepatocellular Carcinoma | Immune Checkpoint Inhibitors

China
Ascletis Pharmaceuticals Co., Ltd.
Hunan Provincial People's Hospital

Completed

A Study of the Relative Bioavailability of ASC41 in Healthy Subjects

Healthy

China
Hunan Cancer Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Hunan Provincial People's...

Unknown

Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer

Non-small Cell Lung Cancer

China
Sun Yat-sen University
Hunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Hunan Cancer Hospital
Henan Cancer Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer

China
Xianhai Mao
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection (ALTER-H006)

Hepatocellular Carcinoma | Adjuvant Therapy

China
Hunan Cancer Hospital
Fuzhou Pulmonary Hospital of Fujian; Chia Tai Tianqing Pharmaceutical Group...

Recruiting

Anlotinib Plus Penpulimab for the Treatment of Sensitive Relapsed Small-Cell Lung Cancer

Small Cell Lung Cancer

China
Changchun BCHT Biotechnology Co.
The First Affiliated Hospital of Yunnan University of Traditional Chinese... and other collaborators

Not yet recruiting

Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1

Rabies Virus Infection

China
GeneScience Pharmaceuticals Co., Ltd.
Children's Hospital of Fudan University; The First Hospital of Jilin University and other collaborators

Unknown

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Small for Gestational Age Infant

China
Beijing Health Guard Biotechnology, Inc
National Institutes for Food and Drug Control, China; Yunnan Center for Disease... and other collaborators

Active, not recruiting

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Human Papillomavirus Infection

China
Funan Liu
Institute of Health and Medical Technology, Hefei Institutes of Physical... and other collaborators

Recruiting

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

Gastric Cancer | Organoids

China
Funan Liu
Institute of Health and Medical Technology, Hefei Institutes of Physical... and other collaborators

Recruiting

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

Colorectal Cancer | Organoids

China
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Hunan Cancer Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and other collaborators

Recruiting

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Breast Cancer | Ovarian Cancer

China
Dongzhimen Hospital, Beijing
Wuhan Third Hospital; The Second Affiliated Hospital of Tianjin University... and other collaborators

Unknown

BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome (BOSS)

Coronary Artery Disease | Diabetic Peripheral Neuropathy | Stroke, Ischemic | Angina Pectoris, Stable

China
GeneScience Pharmaceuticals Co., Ltd.
The Second Hospital of Hebei Medical University; Peking University Third Hospital and other collaborators

Unknown

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Growth Hormone Deficiency

China
Wuhan Union Hospital, China
Zhongshan Hospital Xiamen University; The Affiliated Hospital of Qingdao University and other collaborators

Recruiting

SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial (SPAIR-2)

Stroke, Acute

China
Peking University Third Hospital
General Hospital of Shenyang Military Region; Xijing Hospital; The First Affiliated... and other collaborators

Completed

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study (PACER)

Stroke | Adverse Drug Reaction | Cinepazide

China
Suodi ZHAI
Peking University; The Second Hospital of Hebei Medical University; West China... and other collaborators

Completed

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Adverse Drug Reaction | Drug Allergy

China

Clinical Trials Sponsored by Yunnan PanLongYunHai Pharmaceuticals, Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations